Abstract:"Intelligent" crosslinked nanoparticles (NPs) provide great advantages in enhancing drug bioavailability and reducing side effects in anticancer therapeutics. In this study, a novel biodegradable polyphosphoester-based functional copolymer prodrug PTX-(PBYP-g-MPA)-b-PEEP was prepared to construct pH/redox dual-responsive core-crosslinked nanoparticles (DOX/CCL NPs), in which paclitaxel (PTX) was conjugated to the polyphosphoester to form an amphiphilic prodrug and doxorubicin (DOX) was encapsulated inside the prodrug NPs. At first, PTX was used as an initiator to polymerize 2-(but-3-yn-1-yloxy)-2-oxo-1,3,2-dioxaphospholane (BYP) and 2-ethoxy-2-oxo-1,3,2-dioxaphospholane (EOP) by one-pot sequential ring-opening polymerization, yielding a biodegradable polymeric prodrug PTX-PBYP-b-PEEP. Subsequently, a radical-mediated thiol-yne "click" reaction was performed between the alkynyl groups on the PBYP segment and the thiol group of 3-mercaptopropionic acid (MPA) to form a functional carboxyl group at the side chain. The potential positively charged DOX·HCl can be physically encapsulated via electrostatic interaction with the carboxyl group and hydrophobic interaction. Afterwards, the DOX/CCL NPs with cleavable disulfide (S-S) linkages can be formed by partial crosslinking through amidation between the pendant carboxyl groups and cystamine. These NPs possess multifunctional characteristics used for in vitro drug release. Notably, a redox-responsive crosslinker, cystamine dihydrochloride, and synergetic non-covalent interactions not only stabilize the nanoparticles, achieve high DOX-loading capacity of drug loading content (DLC, 14.6%) and drug loading efficiency (DLE, 73.1%), but also endow the DOX/CCL NPs with controlled drug release capacity, which is due to the cleavage of S-S bonds in the presence of 10 mM glutathione (GSH) and weakened electrostatic interaction caused by the protonation of carboxyl groups at a lower pH (5.0). Moreover, these pH/redox dual-responsive DOX/CCL NPs can be steadily internalized by HeLa cells, exhibiting high-efficiency cellular proliferation inhibition. This study presents a promising strategy for controlled intracellular drug release in cancer therapy.

ROS-responsive core crosslinked micelles by combination of enzymatic polymerization and thiol-ene click chemistry for anticancer drug delivery

Preparation of ROS-responsive Core Crosslinked Polycarbonate Micelles with Thioketal Linkage.

Photodynamic Therapy-Triggered On-Demand Drug Release from ROS-responsive Core-Cross-linked Micelles Toward Synergistic Anti-Cancer Treatment

Redox-Sensitive Core Cross-Linked Polyethylene Glycol-Polypeptide Hybrid Micelles for Anticancer Drug Delivery

Reduction-responsive Disassemblable Core-Cross-linked Micelles Based on Poly(ethylene Glycol)-B-poly(n-2-hydroxypropyl Methacrylamide)-Lipoic Acid Conjugates for Triggered Intracellular Anticancer Drug Release.

Facile Preparation of Core Cross-Linked Nanomicelles Based on Graft Copolymers with Ph Responsivity and Reduction Sensitivity for Doxorubicin Delivery.

Multi-Activated Polymeric Micelles with Charge-Conversion and Ros-Controlled Drug Release for Efficient Cancer Therapy

A Reactive Oxygen Species-Responsive Prodrug Micelle with Efficient Cellular Uptake and Excellent Bioavailability.

Visible-Light-Induced Diselenide-Crosslinked Polymeric Micelles for ROS-Triggered Drug Delivery

Dual-Responsive Core-Crosslinked Polyphosphoester-Based Nanoparticles for Ph/Redox-Triggered Anticancer Drug Delivery

Reduction and Ph Dual-Sensitive Core-Crosslinked Polypeptide Micelles for Triggered Doxorubicin Release

Redox-responsive core cross-linked micelles based on cypate and cisplatin prodrugs-conjugated block copolymers for synergistic photothermal–chemotherapy of cancer

Interface Crosslinked Mpeg-B-page-b-pcl Triblock Copolymer Micelles with High Stability for Anticancer Drug Delivery.

Preparation of pH and redox dual-sensitive core crosslinked micelles for overcoming drug resistance of DOX

Reduction/temperature/pH Multi-Stimuli Responsive Core Cross-Linked Polypeptide Hybrid Micelles for Triggered and Intracellular Drug Release.

Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.

Stimuli-Responsive Shell Cross-Linked Micelles from Amphiphilic Four-Arm Star Copolymers As Potential Nanocarriers for "Ph/redox-Triggered" Anticancer Drug Release

Polymeric Nanoparticles Responsive to Intracellular ROS for Anticancer Drug Delivery.

A new biosafe reactive oxygen species (ROS)-responsive nanoplatform for drug delivery

Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin.

Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.